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Abstract Control of phosphate (Pi) homeostasis is essen-
tial for many biologic functions and inappropriate low levels
of Pi in plasma have been suggested to associate with
several pathological states, including renal stone formation
and stone recurrence. Pi homeostasis is achieved mainly by
adjusting the renal reabsorption of Pi to the body’s require-
ments. This task is performed to a major extent by the Na/Pi
cotransporter NaPi-IIa that is speciWcally expressed in the
brush border membrane of renal proximal tubules. While the
presence of tight junctions in epithelial cells prevents the
diVusion and mixing of the apical and basolateral compo-
nents, the location of a protein within a particular membrane
subdomain (i.e., the presence of NaPi-IIa at the tip of the
apical microvilli) often requires its association with scaVold-
ing elements which directly or indirectly connect the protein
with the underlying cellular cytoskeleton. NaPi-IIa interacts
with the four members of the Na+/H+ exchanger regulatory
factor family as well as with the GABAA-receptor associ-
ated protein . Here we will discuss the most relevant Wnd-
ings regarding the role of these proteins on the expression
and regulation of the cotransporter, as well as the impact that
their absence has in Pi homeostasis.
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Introduction
The need for a proper control of the circulating levels of
phosphate (Pi) is illustrated by several pathologies associ-
ated with either hypo or hyperphosphatemic states. Thus,
hypophosphatemia compromises bone mineralization and
may cause cardiac dysfunction, whereas hyperphosphate-
mia is linked with secondary hyperparathyroidism and
reduced life expectancy (for review see [3, 10]). Plasma
levels of Pi are kept in the low millimolar range due to the
balance between intestinal absorption, bone deposition/
bone resorption, and renal reabsorption (for review see [4]).
Since Pi is freely Wltered in the glomerulus, an eYcient
renal reabsorption is required to prevent a massive urinary
lost of Pi that would otherwise have fatal consequences. In
this regard, hypophosphatemia increases intrarenal produc-
tion of 1,25dihydroxyvitamin D3 (1,25(OH)2D3) which in
turn leads to higher intestinal absorption of Pi and Ca++,
with a concomitant increase in urinary excretion of Ca++.
Hypercalciuria is the most prevalent metabolic alteration in
renal stone disease and recent studies have suggested that
renal reabsorption of Pi is reduced in stone formers and
associates with hypercalciuria [17]. Moreover, renal han-
dling of Pi has been proposed as a predictive factor for renal
stone recurrence. Among the diVerent hypercalciuric syn-
dromes, hereditary hypophosphatemic rickets with hyper-
calciuria has been recently shown to associate with
mutations in one of the transporters involved in renal reab-
sorption of Pi (for review see [3, 10, 28]).
Renal reabsorption of phosphate
Reabsorption of Pi from the primary urine takes place
preferentially along the proximal tubule with very little
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Pi cotransporters from the SLC34 and SLC20 families of
solute carriers are expressed in the brush border membrane
(BBM) of proximal tubular cells: namely NaPi-IIa (SLC34A1)
[8], NaPi-IIc (SLC34A3) [25], and PiT2 (SLC20A2) [30].
NaPi-IIa deWcient mice are hypophosphatemic due to an
increased urinary excretion of Pi despite a heavy upregula-
tion of NaPi-IIc [2]. These Wndings, together with the lack
of phenotype of NaPi-IIc deWcient mice regarding Pi bal-
ance [26], indicate that NaPi-IIa is the major cotransporter
in the murine kidney. Ablation of both NaPi-IIa [7] and
NaPi-IIc [26] results in hypercalcemia and hypercalciuria;
as mentioned above, these changes are probably due to a
1,25(OH)2D3-induced upregulation of intestinal Ca++
absorption. While disregulation of Ca++ homeostasis results
in the formation of renal stones in NaPi-IIa deWcient mice
[7], the absence of NaPi-IIc does not seem to increase renal
mineral deposition [26]. In humans, mutations of NaPi-IIa
have been reported in patients with hypophosphatemic syn-
dromes [21]; however, it is not clear whether these muta-
tions alone can account for the hypophosphatemic state
[31]. Instead, mutations in NaPi-IIc have been identiWed by
several laboratories in a large number of patients with
hereditary hypophosphatemic rickets with hypercalciuria
(for review see [3, 10]). It remains to be shown whether this
diVerent relative contribution of both cotransporters to
overall Pi homeostasis in mouse and human represents a
species-speciWc phenomena or responds to yet unknown
causes.
Within the murine renal proximal tubule NaPi-IIa is
expressed preferentially in the S1 segments and decreases
progressively toward the S2 and S3 portions [8]. Under
normal dietary conditions it is more abundant in juxtame-
dular than in superWcial nephrons. Its expression in the
proximal BBM is under the control of several hormones
[parathyroid hormone (PTH), Wbroblast growth factor 23
(FGF23)] and metabolic factors (1,25(OH)2D3, dietary Pi)
that regulate renal reabsorption of Pi (for review see [4]).
With few exceptions, factors that increase renal reabsorp-
tion of Pi (Pi deprivation) do so by upregulating the apical
expression of NaPi-IIa, whereas factors that reduce renal
reabsorption (PTH, FGF23 or high dietary Pi) lead to down-
regulation of the cotransporter. Thus, understanding the
molecular mechanisms that control the apical expression of
NaPi-IIa is a central issue in Pi homeostasis.
Interaction of NaPi-IIa with PDZ proteins
NaPi-IIa is an integral protein predicted to span the mem-
brane 8–10 times, with cytoplasmic amino and carboxyl-
terminal tails. In order to identify potential NaPi-IIa inter-
acting partners, several intracellular segments of the
cotransporter (amino- and carboxyl-terminal tails as well as
the last intracellular loop) were Wrst used as bait in yeast
two hybrid screenings.
We found that the carboxyl-terminal tail interacts among
other partners with the Na+/H+ exchanger regulatory factors
1 and 2 (NHERF1/EBP50 and NHERF2/E3KARP) as well
as with PDZK1/CAP70/NaPi-Cap1 and PDZK2 (Fig. 1a)
[11]. These last two proteins were recently renamed as
NHERF3 and NHERF4, respectively. NHERF1 and NHERF2
contain two PDZ domains (post-synaptic density protein,
PSD95; Drosophila disk large tumor suppressor, DlgA;
zonula occludens-1 protein, ZO-1) and a carboxyl-terminal
Fig. 1 NaPi-IIa interacts with the four members of the NHERF1 fam-
ily. Schematic representation of NaPi-IIa and the four members of the
NHERF family located on the brush border membrane (BBM) of renal
epithelial cells (a): the interacting PDZ-domains of the NHERF pro-
teins are indicated by asterisks. The Moesin-Ezrin-Radixin-Merlin-
binding domain (MERM-BD) of NHERF1/2 interacts with the
MERM family of actin-binding proteins, providing a bridge to the ac-
tin cytoskeleton. Preventing the association of NaPi-IIa with NHERF1
impairs the apical expression of NaPi-IIa (b modify from [13]): con-
focal microscopy of OK cells transfected with a plasmid encoding the
myc-fused PDZ1 of NHERF1. Cultures were stained for myc-PDZ1
(red), the endogenous NaPi-IIa (green) and actin (white). The patches
represent actin-enriched apical microdomains were NaPi-IIa is
predominantly enriched. The transfected myc-PDZ1 has a dominant
negative eVect, as indicated by the observation that cells expressing
myc-PDZ1 have a reduced expression of NaPi-IIa in the apical micro-
villi despite a normal actin cytoskeleton123
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that indirectly connects with actin. NHERF3 and NHERF4
contain four PDZ domains and their binding to the actin
cytoskeleton has been proposed to be mediated via associa-
tion with NHERF1. Indeed, NHERF1/2 were shown to
interact with the fourth PDZ domain of NHERF3 [12].
NaPi-IIa interacts speciWcally with the Wrst PDZ domain of
NHERF1/2 and with the third PDZ domain of NHERF3/4.
In all four cases, the association is strictly dependent on the
presence of the last three residues of NaPi-IIa (TRL) that
therefore act as a PDZ-binding motif. In our initial screen
we found that NHERF3/4 hits represented about 70% of all
interacting clones, whereas NHERF1/2 hits contributed to
less than 10% [11]. This observation may just reXect the
diVerent relative abundance of transcripts in the kidney
cDNA library. However, in vitro analysis indicated that the
interaction of NaPi-I (a cotransporter which carboxyl-ter-
minal tail has high homology with NaPi-IIa) with NHERF3
is stronger than its association with NHERF1 [12]. The four
NHERF isoforms are coexpressed with NaPi-IIa at the
BBM of renal proximal tubules, but their membrane
expression is not regulated by factors that modulate the api-
cal abundance of the cotransporter.
Interaction of NaPi-IIa with NHERF1: functional eVect
Early experiments showed that removal of just the carboxyl-
terminal TRL residues of NaPi-IIa results in a protein that
accumulates massively in the cytoplasm upon transfection in
proximal epithelial cells, unlike the wild type cotransporter
that is expressed preferentially at the apical membrane [16].
The Wnding that the three terminal residues act as a PDZ-
binding motif allowed us to clarify the molecular mechanism
underlying these early observations. Thus, we could show
that preventing the association of NaPi-IIa with NHERF1, by
transfecting OK cells only with the interacting PDZ domain
of NHERF1 impairs the apical expression of the cotrans-
porter (Fig. 1b) [13]. Together, these Wndings suggested that
the association with NHERF1 via the terminal TRL stabilizes
the expression of NaPi-IIa at the BBM. Such mechanism was
conWrmed when Shenolikar and colleagues published the
generation of the NHERF1 knock out. They reported that the
absence of NHERF1 results in a reduced expression of
NaPi-IIa in the proximal BBM, leading to an increased
urinary excretion of Pi and hypophosphatemia [27].
PTH is a phosphaturic hormone that acts by regulating
the apical expression of NaPi-IIa. PTH binds to a G-protein
coupled receptor able to activate the adenylyl cyclase (AC)/
PKA as well as the phospholipase C (PLC)/PKC pathways.
Both cascades lead to endocytosis and lysosomal degrada-
tion of NaPi-IIa (for review, see [4]). The AC eVect seems
to be solely mediated via the classical PKA pathway, with-
out contribution of the exchange protein directly activated
by cAMP (EPAC) [15]. Unlike NaPi-IIa, NHERF1 is not
endocytosed upon PTH treatment [9], suggesting that the
complex of both proteins must be dissociated prior to inter-
nalization of the cotransporter (Fig. 2a). Indeed the amount
of NaPi-IIa that co-immunoprecipitates with NHREF is
reduced upon incubation with PTH (Fig. 2b). In addition,
incubation with PTH, or pharmacological activation of
PKA or PKC, leads to hyperphosphorylation of NHERF
(Fig. 2c), whereas NaPi-IIa does not seem to be phosphory-
lated either basally or after PTH treatment (Fig. 2d) [9].
Based on these observations, we proposed that phosphory-
lation of NHERF1 could inhibit its association with NaPi-IIa,
thus rendering a cotransporter with reduced stability at the
BBM. This hypothesis was later on conWrmed by EJ
Fig. 2 PTH regulates the association of NaPi-IIa and NHERF1 and in-
creases the phosphorylation of NHERF1. Schematic representation of
the PTH-induced eVects (a): binding of PTH to its receptor results in
phosphorylation of NHERF1 (1), dissociation of NaPi-IIa/NHERF1
complexes (2) and endocytosis of NaPi-IIa (3). PTH treatment reduces
the amount of NaPi-IIa that coimmunoprecipitates (co-IP) with
NHERF1 (b [9]): OK cells were transfected with V5-tagged NaPi-IIa.
Cultures were treated with leupeptin (to prevent lysosomal degrada-
tion) followed by incubation in the absence (¡) or presence (+) of
1–34 PTH. Upon cellular lysis, NHERF1 was immunoprecipitated
with an NHERF antibody, and the immunoprecipitated material was
processed for Western blot with V5 and NHERF1 antibodies. ***
P · 0.001. PTH treatment leads to phosphorylation of NHERF1
(c [9]): slices of mouse kidneys were phosphorylated in the presence of
32P followed by incubation in the absence (¡) or presence (+) of 1–34
PTH. NHERF1 was then pulled down using GST fused to the C-termi-
nal tail of NaPi-I (GST-CT). Upon elution, samples were analyzed for
32P incorporation (top panels) or processed for Western blot with
NHERF1 antibodies (bottom panel). PTH treatment does not induce
phosphorylation of NaPi-IIa (b [9]): kidney slices were phosphory-
lated in the presence of 32P and leupeptin followed by incubation in the
absence (¡) or presence (+) of 1–34 PTH. NaPi-IIa was pulled down
using GST fused to PDZK1 (GST-K1) and process as indicated above.
The top panel shows the 32P autoradiogram and the bottom panel a
Western blot with a NaPi-IIa antibody123
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dissociation of NaPi-IIa/NHERF1 complexes involves
phosphorylation of a serine residue (S77) within the Wrst
PDZ domain of NHERF1.
In addition to its role as a scaVold for membrane pro-
teins, NHERF1 is also known to mediate the assembly of
intracellular signaling molecules (for review see [33]).
Thus, NHERF1 interacts with both the PTH receptor and
PLC, and it has been proposed that NHERF may control the
intracellular pathway activated upon PTH binding [18]. We
had previously reported that although activation of apical
and basolateral PTH receptors results in internalization of
NaPi-IIa they do not share similar intracellular pathways. In
particular, apical receptors seem to activate preferentially
the PKC dependent pathway whereas basolateral receptors
signal preferentially via PKA [29]. Therefore, in collabora-
tion with EJ Weinman’s group we investigated whether the
eVect of 3–34 PTH, a PTH fragment that activates exclu-
sively PKC, is preserved in the absence of NHERF1.
Although 3–34 PTH downregulated NaPi-IIa in wild type
mice, it failed to do so in NHERF1 knock outs [6]. This
failure associated with the inability of PTH to activate PLC
in the mutant mice. Since the expression of NHERF1 in the
renal epithelia is restricted to the BBM, our Wndings are
consistent with the proposal that in the presence of NHERF
the PTH receptors (apical) signal via activation of the PLC/
PKC pathway, whereas in the absence of NHERF these
receptors (basolateral) would signal preferentially through
activation of PKA [18]. Therefore, NHERF does not only
control the basal expression of NaPi-IIa but also the intra-
cellular signals that regulate its abundance.
Interaction of NaPi-IIa with NHERF3: functional eVect
As mentioned above, NHERF3/4 represented about 70% of
all the hits in our yeast two hybrid screen. In addition to
NaPi-IIa, NHERF3 also interacts with several other trans-
porters expressed in the proximal BBM (Na+/H+ exchanger
NHE3, organic cation transporter OCTN1, chloride/formate
exchanger CFEX and urate/anion exchanger URAT1) as
well as with regulatory factors (NHERF1 or PKA-anchoring
protein D-AKAP2) [12]. Due to the presence of 4 PDZ
domains, NHERF3 may form a large network of membrane
proteins and regulatory factors. Similar to NHERF1, the
expression of NHERF3 remains unaVected upon incubation
of kidney samples with PTH, suggesting that PTH also
destabilizes its association with NaPi-IIa. Although
NHERF3 is phosphorylated under basal conditions, PTH or
independent activation of PKA or PKC do not regulate the
phosphorylated status of the protein (Déliot and Hernando,
unpublished observations). This suggests that NHERF3 is
not a target for PTH-activated kinases and that the regulated
dissociation of NaPi-IIa from NHERF3 does not depend on
the same molecular mechanism that its dissociation from
NHERF1.
The membrane expression of NaPi-IIa is not altered in
NHERF3 deWcient mice that also have normal expression
of NHERF1 [5]. Regulation of NaPi-IIa by PTH or in
response to pharmacological activation of PKA and PKC is
also normal in these animals. Only upon challenging with
diets containing high or low Pi levels we could detect subtle
diVerences between wild type and NHERF3 deWcient mice,
namely downregulation of NaPi-IIa in response to high die-
tary Pi is more pronounced in the absence of NHERF3 [5].
Taken together, the four members of the NHERF family
interact with NaPi-IIa in vitro but they do not have redun-
dant roles in vivo. Instead, NHERF1 is speciWcally required
for the stabilization of the cotransporter at the apical mem-
brane and its absence is not compensated by the presence of
the other isoforms in the BBM.
Interaction of NaPi-IIa with GABARAP: functional 
eVect
More recently, in collaboration with OW Moe’s group we
made a new yeast two hybrid screen using as bait the whole
NaPi-IIa protein just with the last terminal TRL truncated.
This study identiWed the GABAA-receptor associated pro-
tein (GABARAP) as a new interacting partner of NaPi-IIa
[22]. The domain of GABARAP involved in the interaction
is located between residues 36 and 68, a stretch shown pre-
viously to mediate association with several other partners,
including GABAA receptors [32]. However, the domain of
NaPi-IIa responsible for the interaction remains elusive, as
our attempts to identify it by using discrete intracellular
domains of NaPi-IIa in GST pull down assays failed.
There are a number of studies showing that GABARAP
promotes the membrane expression of GABAA-receptors in
cell culture; however, the localization of these receptors is
normal in GABARAP deWcient mice [20]. We reported that
these animals have a reduced urinary excretion of Pi associ-
ated with upregulation of NaPi-IIa (Fig. 3) [22]. NHERF1
is also heavily upregulated in the mutant mice. The molecu-
lar explanation for this Wnding remains unknown but does
not seem to involve association of GABARAP with
NHERF1. Despite the defect in renal handling, GABARAP
deWcient mice have normal levels of Pi in serum. This nor-
mophosphatemia is most probably due to a compensatory
reduction of the intestinal absorption of Pi. This compensa-
tion is suggested by the Wnding that NaPi-IIb, the major
cotransporter involved in intestinal absorption of Pi [14,
24], is downregulated in GABARAP knock outs (Fig. 3)
[23]. Interestingly, also NaPi-IIb deWcient mice are normo-
phosphatemic: they seem to compensate the reduced intestinal
absorption of Pi (due to the absence of NaPi-IIb) with an123
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IIa) [24]. Within the intestinal tract, NaPi-IIb is located
preferentially in the ileum and its expression in under con-
trol of 1,25(OH)2D3 (for review see [4]). The expression of
the 25 hydroxyvitamin D-1 hydroxylase (1-OHase), the
enzyme that produces the active form of 1,25(OH)2D3, is
reduced in the kidneys from GABARAP deWcient mice
(Fig. 3), whereas the levels of the catabolic 24 hydroxylase
are similar in both the groups [23]. These data are consis-
tent with a reduced renal synthesis of 1,25(OH)2D3 in the
mutant mice which in turn lead to a reduced expression of
NaPi-IIb. Interestingly, both GABARAP and NaPi-IIb deW-
cient mice are normocalcemic; however, while urinary
excretion of Ca++ is normal in the absence of GABARAP
[23], it is increased in NaPi-IIb deWcient animals [24].
There is no information regarding the presence of renal
mineral deposits in these animals.
Although GABARAP was Wrst identiWed as a ligand of
the -subunit of GABAA receptors, it was later on shown to
interact with several proteins involved in intracellular
traYcking among them the clathrin heavy chain (for review
see [19]). We have evidences that PTH-induced endocytosis
of NaPi-IIa takes place at least partially via clathrin-coated
pits [1], opening the question of whether the absence of
GABARAP would blunt the hormonal eVect. However,
PTH downregulates the expression of NaPi-IIa to compara-
ble levels in wild type and GABARAP deWcient mice. Sim-
ilarly, there are no diVerences in the adaptation of the
cotransporter to acute dietary Pi changes [22].
In summary, NaPi-IIa interacts with the NHERF family of
PDZ proteins as well as with GABARAP. The absence of
NHERF1 results in reduced apical expression of NaPi-IIa,
phosphaturia, hypophosphatemia and impaired PKC-medi-
ated PTH regulation. In contrast, the absence of GABARAP
results in increased apical expression of NaPi-IIa, and reduced
urinary excretion of Pi. However, circulating levels of Pi
remain normal probably due to an intestinal compensation.
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